Table 4.
Initial model | Final model | |||
---|---|---|---|---|
|
OR (95% CIs) |
P-value |
OR (95% CIs) |
P-value |
Male gender |
1.66 (0.88-3.13) |
0.1 |
1.88 (1.03-3.44) |
0.04 |
Age |
1.02 (0.99-1.04) |
0.3 |
|
|
DM |
0.92 (0.49-1.76) |
0.8 |
|
|
Smoking |
0.62 (0.36-1.07) |
0.09 |
0.57 (0.33-0.96) |
0.04 |
CAD |
1.34 (0.65-2.77) |
0.4 |
|
|
PAD |
1.53 (0.65-3.58) |
0.3 |
|
|
Cerebrovascular disease |
0.14 (0.02-1.004) |
0.05 |
0.15 (0.02-1.14) |
0.07 |
Baseline LDL-C (mg/dl) |
0.99 (0.98-0.99) |
<0.001 |
0.99 (0.98-0.99) |
<0.001 |
Combined therapy with statin and ezetimibe |
1.15 (0.56-2.34) |
0.7 |
|
|
Very high potency LDL-C lowering regimen | 1.94 (0.84-4.49) | 0.1 | 2.21(1.15-4.24) | 0.02 |
DM = diabetes mellitus, CAD = coronary artery disease, PAD = peripheral arterial disease, LDL-C = low density lipoprotein-cholesterol.